We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
76
Exelon
EXC
$48.1B
$60.3M 0.24%
1,748,525
-408,050
-19% -$13.7M
RTX icon
77
RTX Corp
RTX
$290B
$60M 0.24%
697,944
+5,007
+0.7% +$416K
BKNG icon
78
Booking.com
BKNG
$156B
$59.6M 0.24%
759,125
+38,350
+5% +$2.97M
UN
79
DELISTED
Unilever NV New York Registry Shares
UN
$59.5M 0.24%
992,006
-6,732
-0.7% -$404K
MMM icon
80
3M
MMM
$91.8B
$58.5M 0.23%
425,952
-22,310
-5% -$3.12M
CVS icon
81
CVS Health
CVS
$135B
$57.7M 0.23%
914,493
+222,346
+32% +$13.2M
INFY icon
82
Infosys
INFY
$51B
$57.5M 0.23%
5,060,561
+502,204
+11% +$5.66M
BHP icon
83
BHP
BHP
$211B
$57.2M 0.23%
1,297,572
+13,986
+1% +$653K
ALL icon
84
Allstate
ALL
$70.6B
$57.1M 0.23%
525,098
+15,991
+3% +$1.67M
BDX icon
85
Becton Dickinson
BDX
$46.4B
$56.7M 0.22%
229,595
+10,790
+5% +$2.66M
QCOM icon
86
Qualcomm
QCOM
$164B
$56.2M 0.22%
737,283
+45,715
+7% +$3.44M
PSX icon
87
Phillips 66
PSX
$82.9B
$55.5M 0.22%
542,341
+152,452
+39% +$15.3M
AZN icon
88
AstraZeneca
AZN
$269B
$54.7M 0.22%
613,272
+69,091
+13% +$5.99M
DUK icon
89
Duke Energy
DUK
$101B
$54.4M 0.22%
567,812
+87,911
+18% +$8M
MDLZ icon
90
Mondelez International
MDLZ
$82.9B
$54.3M 0.21%
981,944
+31,123
+3% +$1.7M
BAX icon
91
Baxter International
BAX
$12.8B
$53.7M 0.21%
614,378
+36,363
+6% +$3.1M
RTN
92
DELISTED
Raytheon Company
RTN
$53.6M 0.21%
272,961
+8,335
+3% +$1.54M
AEP icon
93
American Electric Power
AEP
$70.4B
$53.2M 0.21%
567,852
+15,955
+3% +$1.45M
CELG
94
DELISTED
Celgene Corp
CELG
$53.1M 0.21%
534,986
+4,497
+0.8% +$427K
GS icon
95
Goldman Sachs
GS
$289B
$51.7M 0.2%
249,532
+16,404
+7% +$3.43M
ECL icon
96
Ecolab
ECL
$79.8B
$51.5M 0.2%
260,201
+10,529
+4% +$2.11M
BIIB icon
97
Biogen
BIIB
$30.9B
$50.7M 0.2%
217,807
+84,560
+63% +$19.7M
SONY icon
98
Sony
SONY
$137B
$50.5M 0.2%
4,269,015
+206,115
+5% +$2.33M
SYK icon
99
Stryker
SYK
$135B
$49.8M 0.2%
230,281
+8,930
+4% +$1.92M
TGT icon
100
Target
TGT
$66.3B
$49.4M 0.2%
462,426
+43,341
+10% +$4.12M
2 3
4
5 6

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.